CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) · INSIDERData sourcesSEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago
Public companyCLOVER HEALTH INVESTMENTS, CORP. /DE
CLOVCIK 0001801170
Price$4.82
1 year+62.6%
Disclosed transactions58
Buys / sells0 / 23
Max Insider Score43
Connections with evidence15
CLOV · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 17 | OFOldakowski Joseph FrankChief Accounting Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 186.4K sh | Nov 4, 2026 |
| Nov 6, 2026 traded Nov 4, 2026 |
| 13 | TCThornton Joseph ClayChief Financial Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 328.9K sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 19 | SKSoares KarenChief Legal Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $90K 19.3K sh | Oct 20, 2026 | Oct 20, 2026 traded Oct 20, 2026 | +0d | SEC Form 4 | |
| 13 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $18K 4,066 sh | Oct 19, 2026 | Oct 20, 2026 traded Oct 19, 2026 | +1d | SEC Form 4 | |
| 20 | TCThornton Joseph ClayInterim CFO | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $21K 4,591 sh | Oct 15, 2026 | Oct 19, 2026 traded Oct 15, 2026 | +4d | SEC Form 4 | |
| 19 | WCWai ConradCEO, Counterpart Health | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $111K 23.6K sh | Oct 15, 2026 | Oct 19, 2026 traded Oct 15, 2026 | +4d | SEC Form 4 | |
| 19 | SKSoares KarenChief Legal Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $69K 14.7K sh | Oct 15, 2026 | Oct 19, 2026 traded Oct 15, 2026 | +4d | SEC Form 4 | |
| 22 | TAToy AndrewDirector, Chief Executive Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $291K 62.2K sh | Oct 15, 2026 | Oct 19, 2026 traded Oct 15, 2026 | +4d | SEC Form 4 | |
| 16 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $86K 18.3K sh | Oct 15, 2026 | Oct 19, 2026 traded Oct 15, 2026 | +4d | SEC Form 4 | |
| 13 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $9,288 2,006 sh | Oct 7, 2026 | Oct 7, 2026 traded Oct 7, 2026 | +0d | SEC Form 4 | |
| 13 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $8,760 1,921 sh | Sep 17, 2026 | Sep 18, 2026 traded Sep 17, 2026 | +1d | SEC Form 4 | |
| 33 | WCWai ConradCEO, Counterpart Health | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $1.42M 300.0K sh | Sep 15, 2026 | Sep 16, 2026 traded Sep 15, 2026 | +1d | SEC Form 4 | |
| 20 | SKSoares KarenChief Legal Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $33K 6,846 sh | Sep 15, 2026 | Sep 15, 2026 traded Sep 15, 2026 | +0d | SEC Form 4 | |
| 13 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $44K 9,273 sh | Sep 15, 2026 | Sep 15, 2026 traded Sep 15, 2026 | +0d | SEC Form 4 | |
| 43 | OFOldakowski Joseph FrankVP OF FINANCE AND CONTROLLER | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale | SELL | $103K 20.0K sh | Sep 14, 2026 | Sep 14, 2026 traded Sep 14, 2026 | +0d | SEC Form 4 | |
| 13 | SKSoares KarenChief Legal Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 108.7K sh | Aug 12, 2026 | Aug 13, 2026 traded Aug 12, 2026 | +1d | SEC Form 4 | |
| 9 | TCThornton Joseph ClayInterim CFO | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 54.3K sh | Aug 12, 2026 | Aug 13, 2026 traded Aug 12, 2026 | +1d | SEC Form 4 | |
| 11 | TAToy AndrewDirector, Chief Executive Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $408K 87.8K sh | Aug 10, 2026 | Aug 10, 2026 traded Aug 10, 2026 | +0d | SEC Form 4 | |
| 1 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $11K 2,360 sh | Jun 17, 2026 | Jun 18, 2026 traded Jun 17, 2026 | +1d | SEC Form 4 | |
| 6 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $36K 7,289 sh | Jun 11, 2026 | Jun 11, 2026 traded Jun 11, 2026 | +0d | SEC Form 4 | |
| 20 | WCWai ConradCEO, Counterpart Health | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $879K 220.4K sh | May 28, 2026 | May 28, 2026 traded May 28, 2026 | +0d | SEC Form 4 | |
| 23 | PPPriest Brady PatrickCEO of Clover Care Services | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale | SELL | $345K 98.0K sh | May 13, 2026 | May 13, 2026 traded May 13, 2026 | +0d | SEC Form 4 | |
| 8 | PPPriest Brady PatrickCEO of Clover Care Services | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $79K 36.1K sh | Apr 18, 2026 | Apr 21, 2026 traded Apr 18, 2026 | +3d | SEC Form 4 | |
| 12 | TAToy AndrewDirector, Chief Executive Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $124K 60.8K sh | Apr 15, 2026 | Apr 16, 2026 traded Apr 15, 2026 | +1d | SEC Form 4 | |
| 9 | WCWai ConradCEO, Counterpart Health | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $48K 23.5K sh | Apr 15, 2026 | Apr 16, 2026 traded Apr 15, 2026 | +1d | SEC Form 4 | |
| 5 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $26K 12.7K sh | Apr 15, 2026 | Apr 16, 2026 traded Apr 15, 2026 | +1d | SEC Form 4 | |
| 5 | PPPriest Brady PatrickCEO of Clover Care Services | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $32K 15.5K sh | Apr 15, 2026 | Apr 16, 2026 traded Apr 15, 2026 | +1d | SEC Form 4 | |
| 9 | SKSoares KarenChief Legal Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $21K 10.2K sh | Apr 15, 2026 | Apr 16, 2026 traded Apr 15, 2026 | +1d | SEC Form 4 | |
| 9 | TCThornton Joseph ClayInterim CFO | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $8,482 4,158 sh | Apr 15, 2026 | Apr 16, 2026 traded Apr 15, 2026 | +1d | SEC Form 4 | |
| 5 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $11K 6,197 sh | Apr 3, 2026 | Apr 7, 2026 traded Apr 3, 2026 | +4d | SEC Form 4 | |
| 17 | SKSoares KarenChief Legal Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 382.5K sh | Apr 1, 2026 | Apr 3, 2026 traded Apr 1, 2026 | +2d | SEC Form 4 | |
| 31 | PPPriest Brady PatrickCEO of Home Care | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale | SELL | $380K 175.0K sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 1 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding · 10b5-1 plan | F | $41K 14.7K sh | Jan 15, 2026 | Jan 20, 2026 traded Jan 15, 2026 | +5d | SEC Form 4 | |
| 18 | TAToy AndrewDirector, Chief Executive Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $171K 60.8K sh | Jan 15, 2026 | Jan 20, 2026 traded Jan 15, 2026 | +5d | SEC Form 4 | |
| 18 | WCWai ConradCEO, Counterpart Health | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $73K 25.9K sh | Jan 15, 2026 | Jan 20, 2026 traded Jan 15, 2026 | +5d | SEC Form 4 | |
| 18 | PPPriest Brady PatrickCEO of Home Care | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $51K 18.1K sh | Jan 15, 2026 | Jan 20, 2026 traded Jan 15, 2026 | +5d | SEC Form 4 | |
| 15 | SKSoares KarenGeneral Counsel & Secretary | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $33K 11.7K sh | Jan 15, 2026 | Jan 20, 2026 traded Jan 15, 2026 | +5d | SEC Form 4 | |
| 12 | PPPriest Brady PatrickCEO of Home Care | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $94K 36.9K sh | Jan 18, 2026 | Jan 20, 2026 traded Jan 18, 2026 | +2d | SEC Form 4 | |
| 1 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $12K 4,597 sh | Jan 20, 2026 | Jan 20, 2026 traded Jan 20, 2026 | +0d | SEC Form 4 | |
| 17 | GVGaripalli VivekDirector, 10% Owner | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Option exercise | M | — 1.66M sh | Jan 7, 2026 | Jan 9, 2026 traded Jan 7, 2026 | +2d | SEC Form 4 | |
| 17 | GVGaripalli VivekDirector, 10% Owner | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Option exercise | M | — 3.34M sh | Jan 7, 2026 | Jan 9, 2026 traded Jan 7, 2026 | +2d | SEC Form 4 | |
| 30 | GVGaripalli VivekDirector, 10% Owner | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $4.29M 1.66M sh | Jan 7, 2026 | Jan 9, 2026 traded Jan 7, 2026 | +2d | SEC Form 4 | |
| 21 | GVGaripalli VivekDirector, 10% Owner | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Option exercise | M | — 1.66M sh | Jan 7, 2026 | Jan 9, 2026 traded Jan 7, 2026 | +2d | SEC Form 4 | |
| 9 | GVGaripalli VivekDirector, 10% Owner | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Option exercise | M | — 3.34M sh | Jan 7, 2026 | Jan 9, 2026 traded Jan 7, 2026 | +2d | SEC Form 4 | |
| 13 | KLKouzoukas Demetrios L.Director | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 79.4K sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 13 | LULoengard Anna UDirector | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 79.4K sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 21 | | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 79.4K sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 13 | RGRobinson William G JrDirector | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 79.4K sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 17 | EAEdwards Carladenise ArmbristerDirector | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Grant or award | A | — 79.4K sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 1 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $5,318 2,102 sh | Jan 7, 2026 | Jan 7, 2026 traded Jan 7, 2026 | +0d | SEC Form 4 | |
| 1 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $13K 4,913 sh | Dec 18, 2025 | Dec 18, 2025 traded Dec 18, 2025 | +0d | SEC Form 4 | |
| 5 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $34K 12.6K sh | Dec 14, 2025 | Dec 16, 2025 traded Dec 14, 2025 | +2d | SEC Form 4 | |
| 9 | SKSoares KarenGeneral Counsel & Secretary | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $17K 6,404 sh | Dec 15, 2025 | Dec 16, 2025 traded Dec 15, 2025 | +1d | SEC Form 4 | |
| 5 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $23K 8,691 sh | Dec 15, 2025 | Dec 16, 2025 traded Dec 15, 2025 | +1d | SEC Form 4 | |
| 19 | WCWai ConradCEO, Counterpart Health | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $266K 98.4K sh | Dec 14, 2025 | Dec 16, 2025 traded Dec 14, 2025 | +2d | SEC Form 4 | |
| 9 | SKSoares KarenGeneral Counsel & Secretary | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $18K 7,459 sh | Nov 14, 2025 | Nov 18, 2025 traded Nov 14, 2025 | +4d | SEC Form 4 | |
| 18 | TAToy AndrewDirector, Chief Executive Officer | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Tax withholding | F | $228K 85.5K sh | Nov 8, 2025 | Nov 12, 2025 traded Nov 8, 2025 | +4d | SEC Form 4 | |
| 8 | RLReynoso Jamie L.CEO, Medicare Advantage | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE Open-market sale · 10b5-1 plan | SELL | $109K 30.4K sh | Nov 4, 2025 | Nov 5, 2025 traded Nov 4, 2025 | +1d | SEC Form 4 | |
CEO of Home Care · Jan 20, 2026
Toy AndrewDirector, Chief Executive Officer · Nov 12, 2025